- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03081195
SMART Africa (Strengthening Mental Health Research and Training) (SMART)
SMART Africa: Addressing African Youth Mental Health by Scaling Family and Community-Level EBPs
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A longitudinal experimental mixed methods effectiveness-implementation hybrid research design will be employed. The study will be conducted across thirty primary schools representing both semi-urban and rural communities. We expect to involve 3,000 youth (in primary schools grades 2 through 7; 8 to 13 years) and their adult caregivers (3,000) in Uganda, 180 youth and their caregivers (180) in Ghana, and 180 youth and their caregivers (180) in Kenya.
Schools will be randomly assigned to 3 study conditions: 1) MFG-delivered by trained family peers; 2) MFG-delivered by community health workers (school health education program coordinators in Ghana); or, 3) Comparison: mental health and school support materials (e.g., books, uniforms). Data will be collected at baseline, 8 and 16 weeks, and 6 months follow-up (10 months from baseline).
More specifically the objectives of this study are:
Primary objectives
- To examine short- and long-term outcomes associated with the MFG. Hypothesis: Children in the treatment groups (MFG) will improve significantly more compared to those in the comparison (usual care) group.
To examine how systematic variations in the delivery of an evidence-based MFG program impacts outcomes for children with behavioral difficulties and their caregivers in each country context.
Hypothesis: Children who participate in MFG with their families will display significantly reduced conduct difficulties and increased functioning over time compared to those involved in comparison condition. We expect that parent peers - compared to community health workers - will evidence significantly more success engaging families to attend MFG sessions, thus, children in the MFG-parent peer delivered condition will evidence the great improvement relative to the other two study conditions.
Secondary objectives
To compare the uptake and implementation of MFGs by trained existing family peers and community outreach health workers.
Hypothesis: Given the level of training that community outreach health workers have received prior to the study as part of their regular professional training, they will evidence higher fidelity initially, yet with training and ongoing supervision, we expect these differences to decrease over time.
- To examine multi-level (state/government, NGOs, families, schools, communities) influences on the uptake, implementation, effectiveness and sustainability of EBPs that address serious child disruptive behavioral challenges.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Accra, Ghana
- University of Ghana
-
-
-
-
-
Nairobi, Kenya
- University of Nairobi
-
-
-
-
-
Masaka, Uganda
- Reach the Youth Uganda
-
-
-
-
Missouri
-
St. Louis, Missouri, United States, 63130
- Washington University in St. Louis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Inclusion criteria for caregiver/child dyads:
- Adult caregiver of a child in primary school, grades two through 7, ages 8 to 13 years
- Adult caregiver willing to consent and available for research and intervention activities
- Child between the ages 8 to 13 or in primary school (grades two through seven) who is screened for ODD or CD as measured by the Disruptive Behavior Disorder Rating Scale, Impairment Scale, and Iowa Conners Scale.
Child willing to assent.
- Inclusion criteria for parent peers:
Caregivers of children who agree to be trained to provide support to families.
- Inclusion criteria for community health workers
Lay paraprofessionals who work within primary care settings.
- Inclusion criteria for school directors
- Directors who oversee schools where the proposed intervention will have been tested.
Exclusion Criteria:
- Exclusion criteria for caregiver/child dyads:
- Lack of understanding of study and study procedures as determined by the research team
Child or caregiver refusal to participate
- Exclusion criteria for parent peers:
Refusal to participate
- Exclusion criteria for community health workers
Refusal to participate
- Exclusion criteria for school directors
- Refusal to participate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MFG-delivered by trained family peers
MFG delivered by trained parent peers drawn from local school planning councils: 10 schools; 60 parent peers (6 per school x 10); 1,000 children and adult caregivers; children screened to evidence serious emerging and clinically significant DBDs |
The MFG is a series of weekly meetings guided by a protocol.Over the course of 16 weeks, groups are held weekly and are facilitated by trained and supervised group leaders (in this case either parent peers or community health outreach workers).
Groups can consist of up to 20 families involving adult caregivers and all children over six years of age in the family.
The protocols have been designed to provide opportunities during each session to directly apply content to the realities of family life, emergent cultural and values perspectives, as well as tailor messages to age of child.
Redundancy for missed appointments and opportunities for reinforcement is built in.
We aim for families to attend at least 8 meetings or more (out of 16 sessions in total), as findings suggests this dose is needed to reduce child conduct problems and the majority of families reach this goal.
Other Names:
|
|
Experimental: MFG-delivered by CHWs
MFG delivered by community health workers (CHW) drawn from local primary care clinics: 10 schools; 60 community health workers (6 assigned to children per school x 10); 1,000 children and adult caregivers; children screened to evidence serious emerging and clinically significant DBDs |
The MFG is a series of weekly meetings guided by a protocol.Over the course of 16 weeks, groups are held weekly and are facilitated by trained and supervised group leaders (in this case either parent peers or community health outreach workers).
Groups can consist of up to 20 families involving adult caregivers and all children over six years of age in the family.
The protocols have been designed to provide opportunities during each session to directly apply content to the realities of family life, emergent cultural and values perspectives, as well as tailor messages to age of child.
Redundancy for missed appointments and opportunities for reinforcement is built in.
We aim for families to attend at least 8 meetings or more (out of 16 sessions in total), as findings suggests this dose is needed to reduce child conduct problems and the majority of families reach this goal.
Other Names:
|
|
No Intervention: Bolstered care
Comparison (Bolstered care): Mental health wellness materials and educational supports (e.g. books, uniforms) 10 schools; 1,000 children and adult caregivers; children screened to evidence serious emerging and clinically significant DBDs |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Child disruptive behavior
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
|
Change in disruptive behavior will be measured by Iowa Connors
|
baseline, 8 weeks, 16 weeks, 6 months
|
|
Child impairment
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
|
Change in disruptive behavior will be measured Impairment scale
|
baseline, 8 weeks, 16 weeks, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implementation and Feasibility
Time Frame: 8 weeks, 16 weeks, 6 months
|
implementation and feasibility checklist measures
|
8 weeks, 16 weeks, 6 months
|
|
Fidelity
Time Frame: end of session at week 1, week 2, week 3, week 4, week 6, week 7, week 8, week 9, week 10, week 11, week 12, week 13, week 14, week 15, week 16
|
MFG Intervention Fidelity Assessment measures
|
end of session at week 1, week 2, week 3, week 4, week 6, week 7, week 8, week 9, week 10, week 11, week 12, week 13, week 14, week 15, week 16
|
|
Sustainability
Time Frame: 8 weeks, 16 weeks, 6 months
|
Program Sustainability Assessment Tool
|
8 weeks, 16 weeks, 6 months
|
|
Implementation process
Time Frame: 8 weeks, 16 weeks, 6 months
|
Metropolitan Area Child Study process measure
|
8 weeks, 16 weeks, 6 months
|
|
Parenting
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
|
Change in parenting will be measured by Alabama Parenting questionnaire
|
baseline, 8 weeks, 16 weeks, 6 months
|
|
Social support
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
|
Improvement in social support will be measured by Multidimensional scale of perceived social support -modified
|
baseline, 8 weeks, 16 weeks, 6 months
|
|
Caregiver depression
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
|
Change in caregiver depression will be measured by Center for Epidemiologic Studies Short Depression Scale
|
baseline, 8 weeks, 16 weeks, 6 months
|
|
Caregiver mental health
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
|
Change in caregiver mental health will be measured by Brief Symptom Checklist
|
baseline, 8 weeks, 16 weeks, 6 months
|
|
Caregiver stress
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
|
Change in caregiver stress will be measured by parent stress index short form
|
baseline, 8 weeks, 16 weeks, 6 months
|
|
Child mental health
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
|
Change in Child mental health will be measured by Strengths and Difficulties questionnaire
|
baseline, 8 weeks, 16 weeks, 6 months
|
|
Child self-concept
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
|
Change in child self-concept will be measured by tennessee self-concept
|
baseline, 8 weeks, 16 weeks, 6 months
|
|
Child depression
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
|
Change in child depression will be measured by child depression scale
|
baseline, 8 weeks, 16 weeks, 6 months
|
|
Family relations
Time Frame: baseline, 8 weeks, 16 weeks, 6 months
|
Change in family relations will be measured by Family Relations and Cohesion scale
|
baseline, 8 weeks, 16 weeks, 6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Fred Ssewamala, PhD, Washington University School of Medicine
- Principal Investigator: Mary McKay, PhD, Washington University School of Medicine
Publications and helpful links
General Publications
- Brathwaite R, Ssewamala FM, Sensoy Bahar O, McKay MM, Neilands TB, Namatovu P, Kiyingi J, Zmachinski L, Nabayinda J, Huang KY, Kivumbi A, Bhana A, Mwebembezi A, Petersen I, Hoagwood K; SMART Africa - Uganda Field Team. The longitudinal impact of an evidence-based multiple family group intervention (Amaka Amasanyufu) on oppositional defiant disorder and impaired functioning among children in Uganda: analysis of a cluster randomized trial from the SMART Africa-Uganda scale-up study (2016-2022). J Child Psychol Psychiatry. 2022 Nov;63(11):1252-1260. doi: 10.1111/jcpp.13566. Epub 2022 Jan 6.
- Asampong E, Ibrahim A, Sensoy-Bahar O, Kumbelim K, Yaro PB, McKay MM, Ssewamala FM. Adaptation and Implementation of the Multiple-Family Group Intervention in Ghana. Psychiatr Serv. 2021 May 1;72(5):571-577. doi: 10.1176/appi.ps.201900626. Epub 2021 Jan 12.
- Ssewamala FM, Sensoy Bahar O, McKay MM, Hoagwood K, Huang KY, Pringle B. Strengthening mental health and research training in Sub-Saharan Africa (SMART Africa): Uganda study protocol. Trials. 2018 Aug 6;19(1):423. doi: 10.1186/s13063-018-2751-z.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- U19MH110001-011
- U19MH110001 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Comparison Group
-
Texas Tech UniversityCompletedControl Group | Comparison Group | Intervention GroupUnited States
-
Assistance Publique - Hôpitaux de ParisAllerganCompletedCOMPARISON BETWEEN GROUP TREATED WITH BOTULINUM TOXIN AND PLACEBOFrance
-
Rigshospitalet, DenmarkRecruitingComparison, SocialDenmark
-
ExactechRecruitingTechnology | ComparisonNetherlands
-
Yuzuncu Yil UniversityCompletedComparison | EvaluationTurkey (Türkiye)
-
Muş Alparslan UniversityCompletedLearned Helplessness | Social ComparisonTurkey
-
Ain Shams UniversityEgyptian Center for Research and Regenerative MedicineCompleted
-
University of MalayaCompletedComparison of Onset TimeMalaysia
-
Cairo UniversityCompleted
-
Daniel Nalos MDCompletedCervical Plexus Block ComparisonCzech Republic
Clinical Trials on MFG
-
University of ArizonaInstitute for Mental Health ResearchCompletedSchizophrenia | Schizoaffective Disorder | Major Depression With Psychotic Features | Bipolar Disorder With Psychotic Features | Psychotic Disorder Not Otherwise Specified (NOS) | Recent-Onset PsychosisUnited States
-
Washington University School of MedicineNational Institute of Mental Health (NIMH)Active, not recruiting
-
NYU Silver School of Social WorkCompletedMental Health Wellness 1United States
-
NYU Silver School of Social WorkCompleted
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)CompletedConduct Disorder | Oppositional Defiant DisorderUnited States
-
Washington University School of MedicineNational Institute of Mental Health (NIMH)Active, not recruiting
-
Washington University School of MedicineNational Institute of Mental Health (NIMH)Completed
-
Washington University School of MedicineNational Institute of Mental Health (NIMH)Completed
-
VA Office of Research and DevelopmentCompletedDepression | Posttraumatic Stress Disorders | Mild Traumatic Brain InjuryUnited States
-
Yale UniversityCompletedSchizophrenia and Disorders With Psychotic FeaturesUnited States